Based on suppression assays conducted in vitro, tumor-infiltrating Treg in colorectal cancer can exert immunosuppressive functions via programmed death-ligand 1 (PD-L1), IL-10 and TGF-β [16, 19]. This evidence concerns the gene TGFB1 and colorectal cancer.